Skip to main content
Top
Published in: European Journal of Pediatrics 7/2012

Open Access 01-07-2012 | Review

Clinical practice

Coeliac disease

Authors: C. M. Frank Kneepkens, B. Mary E. von Blomberg

Published in: European Journal of Pediatrics | Issue 7/2012

Login to get access

Abstract

Coeliac disease (CD) is an immune-mediated systemic condition elicited by gluten and related prolamines in genetically predisposed individuals and characterised by gluten-induced symptoms and signs, specific antibodies, a specific human leukocyte antigen (HLA) type and enteropathy. The risk of coeliac disease is increased in first-degree relatives, certain syndromes including Down syndrome and autoimmune disorders. It is thought to occur in 1 in 100–200 individuals, but still only one in four cases is diagnosed. Small-bowel biopsy is no longer deemed necessary in a subgroup of patients, i.e. when all of the following are present: typical symptoms or signs, high titres of and transglutaminase antibodies, endomysial antibodies, and HLA-type DQ2 or DQ8. In all other cases, small-bowel biopsy remains mandatory for a correct diagnosis. Therapy consists of a strictly gluten-free diet. This should result in complete disappearance of symptoms and of serological markers. Adequate follow-up is considered essential. Conclusion: Although small-bowel biopsy may be omitted in a minority of patients, small-bowel biopsy is essential for a correct diagnosis of CD in all other cases. Diagnostic work-up should be completed before treatment with gluten-free diet instituted.
Literature
1.
go back to reference Akobeng AK, Thomas AG (2008) Systematic review: tolerable amount of gluten for people with coeliac disease. Aliment Pharmacol Ther 27:1044–1052PubMedCrossRef Akobeng AK, Thomas AG (2008) Systematic review: tolerable amount of gluten for people with coeliac disease. Aliment Pharmacol Ther 27:1044–1052PubMedCrossRef
2.
go back to reference Akobeng AK, Ramanan AV, Buchan I, Heller RF (2006) Effect of breast feeding on risk of coeliac disease: a systematic review and meta-analysis of observational studies. Arch Dis Child 91:39–43PubMedCrossRef Akobeng AK, Ramanan AV, Buchan I, Heller RF (2006) Effect of breast feeding on risk of coeliac disease: a systematic review and meta-analysis of observational studies. Arch Dis Child 91:39–43PubMedCrossRef
3.
go back to reference Arentz-Hansen H, Korner R, Molberg O et al (2000) The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med 191:603–612PubMedCrossRef Arentz-Hansen H, Korner R, Molberg O et al (2000) The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med 191:603–612PubMedCrossRef
4.
go back to reference Arguelles‐Grande C, Tennyson CA, Lewis SK et al (2012) Variability in small bowel histopathology reporting between different pathology practice settings: Impact on the diagnosis of coeliac disease. J Clin Pathol 65:242–247 Arguelles‐Grande C, Tennyson CA, Lewis SK et al (2012) Variability in small bowel histopathology reporting between different pathology practice settings: Impact on the diagnosis of coeliac disease. J Clin Pathol 65:242–247
5.
go back to reference Auricchio S, Greco L, Troncone R (1988) Gluten-sensitive enteropathy in childhood. Pediatr Clin North Am 35:157–187PubMed Auricchio S, Greco L, Troncone R (1988) Gluten-sensitive enteropathy in childhood. Pediatr Clin North Am 35:157–187PubMed
6.
7.
go back to reference Biagi F, Klersy C, Balduzzi D, Corazza GR (2010) Are we not over-estimating the prevalence of coeliac disease in the general population? Ann Med 42:55761CrossRef Biagi F, Klersy C, Balduzzi D, Corazza GR (2010) Are we not over-estimating the prevalence of coeliac disease in the general population? Ann Med 42:55761CrossRef
8.
go back to reference Bodd M, Kim CY, Lundin KE, Sollid LM (2012) T‐cell response to gluten in patients with HLA‐DQ2.2 reveals requirement of peptide‐MHC stability in celiac disease. Gastroenterology 142:552–561 Bodd M, Kim CY, Lundin KE, Sollid LM (2012) T‐cell response to gluten in patients with HLA‐DQ2.2 reveals requirement of peptide‐MHC stability in celiac disease. Gastroenterology 142:552–561
9.
go back to reference Bourgey M, Calcagno G, Tinto N et al (2007) HLA related genetic risk for coeliac disease. Gut 56:1054–1059PubMedCrossRef Bourgey M, Calcagno G, Tinto N et al (2007) HLA related genetic risk for coeliac disease. Gut 56:1054–1059PubMedCrossRef
10.
go back to reference Branski D, Faber J, Freier S et al (1998) Histologic evaluation of endoscopic versus suction biopsies of small intestinal mucosae in children with and without celiac disease. J Pediatr Gastroenterol Nutr 27:6–11PubMedCrossRef Branski D, Faber J, Freier S et al (1998) Histologic evaluation of endoscopic versus suction biopsies of small intestinal mucosae in children with and without celiac disease. J Pediatr Gastroenterol Nutr 27:6–11PubMedCrossRef
11.
go back to reference Breuning MH, van den Berg-Loonen EM, Bernini LF et al (1977) Localization of HLA on the short arm of chromosome 6. Hum Genet 37:131–139PubMedCrossRef Breuning MH, van den Berg-Loonen EM, Bernini LF et al (1977) Localization of HLA on the short arm of chromosome 6. Hum Genet 37:131–139PubMedCrossRef
12.
go back to reference Bruce SE, Bjarnason I, Peters TJ (1985) Human jejunal transglutaminase: demonstration of activity, enzyme kinetics and substrate specificity with special relation to gliadin and coeliac disease. Clin Sci (Lond) 68:573–579 Bruce SE, Bjarnason I, Peters TJ (1985) Human jejunal transglutaminase: demonstration of activity, enzyme kinetics and substrate specificity with special relation to gliadin and coeliac disease. Clin Sci (Lond) 68:573–579
13.
go back to reference Catassi C, Fabiani E, Iacono G et al (2007) A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease. Am J Clin Nutr 85:160–166PubMed Catassi C, Fabiani E, Iacono G et al (2007) A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease. Am J Clin Nutr 85:160–166PubMed
14.
go back to reference Chirdo FG, Rumbo M, Añón MC, Fossati CA (1998) Presence of high levels of non-degraded gliadin in breast milk from healthy mothers. Scand J Gastroenterol 33:1186–1192PubMedCrossRef Chirdo FG, Rumbo M, Añón MC, Fossati CA (1998) Presence of high levels of non-degraded gliadin in breast milk from healthy mothers. Scand J Gastroenterol 33:1186–1192PubMedCrossRef
16.
go back to reference Collin P, Thorell L, Kaukinen K, Mäki M (2004) The safe threshold for gluten contamination in gluten-free products. Can trace amounts be accepted in the treatment of coeliac disease? Aliment Pharmacol Ther 19:1277–1283PubMedCrossRef Collin P, Thorell L, Kaukinen K, Mäki M (2004) The safe threshold for gluten contamination in gluten-free products. Can trace amounts be accepted in the treatment of coeliac disease? Aliment Pharmacol Ther 19:1277–1283PubMedCrossRef
17.
go back to reference Collin P, Kaukinen K, Vogelsang H et al (2005) Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: a biopsy-proven European multicentre study. Eur J Gastroenterol Hepatol 17:85–91PubMedCrossRef Collin P, Kaukinen K, Vogelsang H et al (2005) Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: a biopsy-proven European multicentre study. Eur J Gastroenterol Hepatol 17:85–91PubMedCrossRef
18.
go back to reference Crespo Pérez L, Castillejo de Villasante G, Cano Ruiz A, León F (2012) Non-dietary therapeutic clinical trials in coeliac disease. Eur J Intern Med 23:9–14PubMedCrossRef Crespo Pérez L, Castillejo de Villasante G, Cano Ruiz A, León F (2012) Non-dietary therapeutic clinical trials in coeliac disease. Eur J Intern Med 23:9–14PubMedCrossRef
19.
go back to reference Csizmadia CG, Mearin ML, von Blomberg BM et al (1999) An iceberg of childhood coeliac disease in the Netherlands. Lancet 353:813–814PubMedCrossRef Csizmadia CG, Mearin ML, von Blomberg BM et al (1999) An iceberg of childhood coeliac disease in the Netherlands. Lancet 353:813–814PubMedCrossRef
20.
go back to reference Dahlbom I, Korponay-Szabo IR, Kovacs JB et al (2010) Prediction of clinical and mucosal severity of coeliac disease and dermatitis herpetiformis by quantification of IgA/IgG serum antibodies to tissue transglutaminase. J Pediatr Gastroenterol Nutr 50:140–146PubMedCrossRef Dahlbom I, Korponay-Szabo IR, Kovacs JB et al (2010) Prediction of clinical and mucosal severity of coeliac disease and dermatitis herpetiformis by quantification of IgA/IgG serum antibodies to tissue transglutaminase. J Pediatr Gastroenterol Nutr 50:140–146PubMedCrossRef
21.
go back to reference Damen GM, Boersma B, Wit JM, Heymans HSA (1994) Catch-up growth in 60 children with celiac disease. J Pediatr Gastroenterol Nutr 19:394–400PubMedCrossRef Damen GM, Boersma B, Wit JM, Heymans HSA (1994) Catch-up growth in 60 children with celiac disease. J Pediatr Gastroenterol Nutr 19:394–400PubMedCrossRef
22.
go back to reference de Magistris L, Familiari V, Pascotto A et al (2010) Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. J Pediatr Gastroenterol Nutr 51:418–424PubMedCrossRef de Magistris L, Familiari V, Pascotto A et al (2010) Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. J Pediatr Gastroenterol Nutr 51:418–424PubMedCrossRef
23.
go back to reference Dieterich W, Ehnis T, Bauer M et al (1997) Identification of tissue transglutaminase as the autoantigen of coeliac disease. Nat Med 3:797–801PubMedCrossRef Dieterich W, Ehnis T, Bauer M et al (1997) Identification of tissue transglutaminase as the autoantigen of coeliac disease. Nat Med 3:797–801PubMedCrossRef
24.
go back to reference Ellis HJ, Ciclitira PJ (2008) Should coeliac sufferers be allowed their oats? Eur J Gastroenterol Hepatol 20:492–493PubMedCrossRef Ellis HJ, Ciclitira PJ (2008) Should coeliac sufferers be allowed their oats? Eur J Gastroenterol Hepatol 20:492–493PubMedCrossRef
25.
26.
go back to reference Fitzpatrick KP, Sherman PM, Ipp M et al (2001) Screening for celiac disease in children with recurrent abdominal pain. J Pediatr Gastroenterol Nutr 33:250–252PubMedCrossRef Fitzpatrick KP, Sherman PM, Ipp M et al (2001) Screening for celiac disease in children with recurrent abdominal pain. J Pediatr Gastroenterol Nutr 33:250–252PubMedCrossRef
27.
go back to reference Frost AR, Band MM, Conway GS (2009) Serological screening for coeliac disease in adults with Turner’s syndrome: prevalence and clinical significance of endomysium antibody positivity. Eur J Endocrinol 160:675–679PubMedCrossRef Frost AR, Band MM, Conway GS (2009) Serological screening for coeliac disease in adults with Turner’s syndrome: prevalence and clinical significance of endomysium antibody positivity. Eur J Endocrinol 160:675–679PubMedCrossRef
28.
go back to reference George EK, Mearin ML, Franken HC et al (1997) Twenty years of childhood coeliac disease in The Netherlands: a rapidly increasing incidence? Gut 40:61–66PubMed George EK, Mearin ML, Franken HC et al (1997) Twenty years of childhood coeliac disease in The Netherlands: a rapidly increasing incidence? Gut 40:61–66PubMed
29.
go back to reference Gijsbers CFM, Kneepkens CMF, Schweizer JJ et al (2011) Recurrent abdominal pain in 200 children: somatic causes and diagnostic criteria. Acta Paediatr 100:e208–e214PubMedCrossRef Gijsbers CFM, Kneepkens CMF, Schweizer JJ et al (2011) Recurrent abdominal pain in 200 children: somatic causes and diagnostic criteria. Acta Paediatr 100:e208–e214PubMedCrossRef
30.
go back to reference Grainge MJ, West J, Solaymani-Dodaran M et al (2012) The long-term risk of malignancy following a diagnosis of coeliac disease or dermatitis herpetiformis: a cohort study. Aliment Pharmacol Ther 35(6):730–739PubMedCrossRef Grainge MJ, West J, Solaymani-Dodaran M et al (2012) The long-term risk of malignancy following a diagnosis of coeliac disease or dermatitis herpetiformis: a cohort study. Aliment Pharmacol Ther 35(6):730–739PubMedCrossRef
31.
go back to reference Greco L, Romino R, Coto I et al (2002) The first large population based twin study of coeliac disease. Gut 50:624–628PubMedCrossRef Greco L, Romino R, Coto I et al (2002) The first large population based twin study of coeliac disease. Gut 50:624–628PubMedCrossRef
32.
go back to reference Guandalini S, Ventura A, Ansaldi N et al (1989) Diagnosis of coeliac disease: time for a change? Arch Dis Child 64:1320–1324PubMedCrossRef Guandalini S, Ventura A, Ansaldi N et al (1989) Diagnosis of coeliac disease: time for a change? Arch Dis Child 64:1320–1324PubMedCrossRef
33.
go back to reference Haboubi NY, Taylor S, Jones S (2006) Coeliac disease and oats: a systematic review. Postgrad Med J 82:672–678PubMedCrossRef Haboubi NY, Taylor S, Jones S (2006) Coeliac disease and oats: a systematic review. Postgrad Med J 82:672–678PubMedCrossRef
34.
go back to reference Hill PG, Holmes GK (2008) Coeliac disease: a biopsy is not always necessary for diagnosis. Aliment Pharmacol Ther 27:572–577PubMedCrossRef Hill PG, Holmes GK (2008) Coeliac disease: a biopsy is not always necessary for diagnosis. Aliment Pharmacol Ther 27:572–577PubMedCrossRef
35.
go back to reference Hill ID, Dirks MH, Liptak GS et al (2005) Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 40:1–19PubMedCrossRef Hill ID, Dirks MH, Liptak GS et al (2005) Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 40:1–19PubMedCrossRef
36.
go back to reference Hogen Esch CE, Wolters VM, Gerritsen SA et al (2011) Specific celiac disease antibodies in children on a gluten-free diet. Pediatrics (in press) Hogen Esch CE, Wolters VM, Gerritsen SA et al (2011) Specific celiac disease antibodies in children on a gluten-free diet. Pediatrics (in press)
37.
go back to reference Holm K, Mäki M, Vuolteenaho N et al (2006) Oats in the treatment of childhood coeliac disease: a 2-year controlled trial and a long-term clinical follow-up study. Aliment Pharmacol Ther 23:1463–1472PubMedCrossRef Holm K, Mäki M, Vuolteenaho N et al (2006) Oats in the treatment of childhood coeliac disease: a 2-year controlled trial and a long-term clinical follow-up study. Aliment Pharmacol Ther 23:1463–1472PubMedCrossRef
38.
go back to reference Husby S, Koletzko S, Korponay-Szabó IR et al (2012) ESPGHAN guidelines for the diagnosis of coeliac disease in children and adolescents. An evidence-based approach. J Pediatr Gastroenterol Nutr 54:136–160PubMedCrossRef Husby S, Koletzko S, Korponay-Szabó IR et al (2012) ESPGHAN guidelines for the diagnosis of coeliac disease in children and adolescents. An evidence-based approach. J Pediatr Gastroenterol Nutr 54:136–160PubMedCrossRef
39.
go back to reference Ivarsson A, Persson LA, Nyström L et al (2000) Epidemic of coeliac disease in Swedish children. Acta Paediatr 89:165–171PubMedCrossRef Ivarsson A, Persson LA, Nyström L et al (2000) Epidemic of coeliac disease in Swedish children. Acta Paediatr 89:165–171PubMedCrossRef
40.
go back to reference Ivarsson A, Hernell O, Stenlund H, Persson LA (2002) Breast-feeding protects against celiac disease. Am J Clin Nutr 75:914–921PubMed Ivarsson A, Hernell O, Stenlund H, Persson LA (2002) Breast-feeding protects against celiac disease. Am J Clin Nutr 75:914–921PubMed
41.
go back to reference Ivarsson A, Hernell O, Nyström L, Persson LA (2003) Children born in the summer have increased risk for coeliac disease. J Epidemiol Community Health 57:36–39PubMedCrossRef Ivarsson A, Hernell O, Nyström L, Persson LA (2003) Children born in the summer have increased risk for coeliac disease. J Epidemiol Community Health 57:36–39PubMedCrossRef
42.
go back to reference Jackson JR, Eaton WW, Cascella NG et al (2011) Neurologic and psychiatric manifestations of celiac disease and gluten sensitivity. Psychiatr Q 83(1):91–102CrossRef Jackson JR, Eaton WW, Cascella NG et al (2011) Neurologic and psychiatric manifestations of celiac disease and gluten sensitivity. Psychiatr Q 83(1):91–102CrossRef
43.
go back to reference Kneepkens CMF, Hoekstra JH (1996) Chronic nonspecific diarrhea: pathophysiology and management. Pediatr Clin North Am 43:375–390PubMedCrossRef Kneepkens CMF, Hoekstra JH (1996) Chronic nonspecific diarrhea: pathophysiology and management. Pediatr Clin North Am 43:375–390PubMedCrossRef
44.
go back to reference Lionetti E, Catassi C (2011) New clues in celiac disease epidemiology, pathogenesis, clinical manifestations, and treatment. Int Rev Immunol 30:219–231PubMedCrossRef Lionetti E, Catassi C (2011) New clues in celiac disease epidemiology, pathogenesis, clinical manifestations, and treatment. Int Rev Immunol 30:219–231PubMedCrossRef
45.
go back to reference Lionetti E, Francavilla R, Pavone P et al (2010) The neurology of coeliac disease in childhood: what is the evidence? A systematic review and meta-analysis. Dev Med Child Neurol 52:700–707PubMedCrossRef Lionetti E, Francavilla R, Pavone P et al (2010) The neurology of coeliac disease in childhood: what is the evidence? A systematic review and meta-analysis. Dev Med Child Neurol 52:700–707PubMedCrossRef
46.
go back to reference Littlewood JM, Crollick AJ, Richards IDG (1980) Childhood coeliac disease is disappearing. Lancet 316:1359CrossRef Littlewood JM, Crollick AJ, Richards IDG (1980) Childhood coeliac disease is disappearing. Lancet 316:1359CrossRef
47.
go back to reference Lohi S, Mustalahti K, Kaukinen K et al (2007) Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther 26:1217–1225PubMedCrossRef Lohi S, Mustalahti K, Kaukinen K et al (2007) Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther 26:1217–1225PubMedCrossRef
48.
go back to reference Louka AS, Nilsson S, Olsson M et al (2002) HLA in coeliac disease families: a novel test of risk modification by the ‘other’ haplotype when at least one DQA1*05-DQB1*02 haplotype is carried. Tissue Antigens 60:147–154PubMedCrossRef Louka AS, Nilsson S, Olsson M et al (2002) HLA in coeliac disease families: a novel test of risk modification by the ‘other’ haplotype when at least one DQA1*05-DQB1*02 haplotype is carried. Tissue Antigens 60:147–154PubMedCrossRef
49.
go back to reference Maglio M, Tosco A, Paparo F et al (2010) Serum and intestinal celiac disease-associated antibodies in children with celiac disease younger than 2 years of age. J Pediatr Gastroenterol Nutr 50:43–48PubMedCrossRef Maglio M, Tosco A, Paparo F et al (2010) Serum and intestinal celiac disease-associated antibodies in children with celiac disease younger than 2 years of age. J Pediatr Gastroenterol Nutr 50:43–48PubMedCrossRef
50.
go back to reference Marsh MN (1989) Studies of intestinal lymphoid tissue. XIII. Immunopathology of the evolving celiac sprue lesion. Pathol Res Pract 185:774–777PubMedCrossRef Marsh MN (1989) Studies of intestinal lymphoid tissue. XIII. Immunopathology of the evolving celiac sprue lesion. Pathol Res Pract 185:774–777PubMedCrossRef
51.
go back to reference Marsh MN (1992) Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (celiac sprue). Gastroenterology 102:330–335PubMed Marsh MN (1992) Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (celiac sprue). Gastroenterology 102:330–335PubMed
52.
go back to reference Marsh MN, Crowe PT (1995) Morphology of the mucosal lesion in gluten sensitivity. Baillieres Clin Gastroenterol 9:273–293PubMedCrossRef Marsh MN, Crowe PT (1995) Morphology of the mucosal lesion in gluten sensitivity. Baillieres Clin Gastroenterol 9:273–293PubMedCrossRef
53.
go back to reference Metso S, Hyytiä-Ilmonen H, Kaukinen K et al (2012) Gluten-free diet and autoimmune thyroiditis in patients with celiac disease. A prospective controlled study. Scand J Gastroenterol 47:43–48PubMedCrossRef Metso S, Hyytiä-Ilmonen H, Kaukinen K et al (2012) Gluten-free diet and autoimmune thyroiditis in patients with celiac disease. A prospective controlled study. Scand J Gastroenterol 47:43–48PubMedCrossRef
54.
go back to reference Meuwisse GW (1970) Round table discussion. Diagnostic criteria in coeliac disease. Acta Paediatr Scand 59:461–463CrossRef Meuwisse GW (1970) Round table discussion. Diagnostic criteria in coeliac disease. Acta Paediatr Scand 59:461–463CrossRef
55.
go back to reference Mitea C, Havenaar R, Drijfhout JW et al (2008) Efficient degradation of gluten by a prolyl endoprotease in a gastrointestinal model: implications for coeliac disease. Gut 57:25–32PubMedCrossRef Mitea C, Havenaar R, Drijfhout JW et al (2008) Efficient degradation of gluten by a prolyl endoprotease in a gastrointestinal model: implications for coeliac disease. Gut 57:25–32PubMedCrossRef
56.
go back to reference Mubarak A, Oudshoorn JH, Kneepkens CMF et al (2011) A child with refractory coeliac disease. J Pediatr Gastroenterol Nutr 53:216–218PubMedCrossRef Mubarak A, Oudshoorn JH, Kneepkens CMF et al (2011) A child with refractory coeliac disease. J Pediatr Gastroenterol Nutr 53:216–218PubMedCrossRef
57.
go back to reference Mubarak A, Spierings E, Wolters VM et al (2012) The human leukocyte antigen DQ2.2 and celiac disease. J Pediatr Gastroenterol Nutr (in press) Mubarak A, Spierings E, Wolters VM et al (2012) The human leukocyte antigen DQ2.2 and celiac disease. J Pediatr Gastroenterol Nutr (in press)
58.
go back to reference Myléus A, Ivarsson A, Webb C et al (2009) Celiac disease revealed in 3 % of Swedish 12-year-olds born during an epidemic. J Pediatr Gastroenterol Nutr 49:170–176PubMedCrossRef Myléus A, Ivarsson A, Webb C et al (2009) Celiac disease revealed in 3 % of Swedish 12-year-olds born during an epidemic. J Pediatr Gastroenterol Nutr 49:170–176PubMedCrossRef
59.
go back to reference National Institute for Health and Clinical Excellence (NICE) (2009) Coeliac disease. Recognition and assessment of coeliac disease. NICE (Clinical guideline 86), London National Institute for Health and Clinical Excellence (NICE) (2009) Coeliac disease. Recognition and assessment of coeliac disease. NICE (Clinical guideline 86), London
60.
go back to reference Naveh Y, Rosenthal E, Ben-Arieh Y, Etzioni A (1999) Celiac disease-associated alopecia in childhood. J Pediatr 134:362–364PubMedCrossRef Naveh Y, Rosenthal E, Ben-Arieh Y, Etzioni A (1999) Celiac disease-associated alopecia in childhood. J Pediatr 134:362–364PubMedCrossRef
61.
go back to reference Norris JM, Barriga K, Hoffenberg EJ et al (2005) Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease. JAMA 293:2343–2351PubMedCrossRef Norris JM, Barriga K, Hoffenberg EJ et al (2005) Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease. JAMA 293:2343–2351PubMedCrossRef
62.
go back to reference Oberhuber G, Granditsch G, Vogelsang H (1999) The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 11:1185–1194PubMedCrossRef Oberhuber G, Granditsch G, Vogelsang H (1999) The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 11:1185–1194PubMedCrossRef
63.
go back to reference Oderda G, Ansaldi N (1987) Comparison of suction capsule and endoscopic biopsy of small bowel mucosa. Gastrointest Endosc 33:265–266PubMedCrossRef Oderda G, Ansaldi N (1987) Comparison of suction capsule and endoscopic biopsy of small bowel mucosa. Gastrointest Endosc 33:265–266PubMedCrossRef
64.
go back to reference Panetta F, Nobili V, Sartorelli MR et al (2012) Celiac disease in pediatric patients with autoimmune hepatitis: etiology, diagnosis, and management. Paediatr Drugs 14:35–41PubMedCrossRef Panetta F, Nobili V, Sartorelli MR et al (2012) Celiac disease in pediatric patients with autoimmune hepatitis: etiology, diagnosis, and management. Paediatr Drugs 14:35–41PubMedCrossRef
65.
go back to reference Peräaho M, Kaukinen K, Paasikivi K et al (2003) Wheat-starch-based gluten-free products in the treatment of newly detected coeliac disease: prospective and randomized study. Aliment Pharmacol Ther 17:587–594PubMedCrossRef Peräaho M, Kaukinen K, Paasikivi K et al (2003) Wheat-starch-based gluten-free products in the treatment of newly detected coeliac disease: prospective and randomized study. Aliment Pharmacol Ther 17:587–594PubMedCrossRef
66.
go back to reference Petronzelli F, Bonamico M, Ferrante P et al (1997) Genetic contribution of the HLA region to the familial clustering of coeliac disease. Ann Hum Genet 61:307–317PubMedCrossRef Petronzelli F, Bonamico M, Ferrante P et al (1997) Genetic contribution of the HLA region to the familial clustering of coeliac disease. Ann Hum Genet 61:307–317PubMedCrossRef
67.
go back to reference Ravikumara M, Tuthill DP, Jenkins HR (2006) The changing clinical presentation of coeliac disease. Arch Dis Child 91:969–971PubMedCrossRef Ravikumara M, Tuthill DP, Jenkins HR (2006) The changing clinical presentation of coeliac disease. Arch Dis Child 91:969–971PubMedCrossRef
68.
go back to reference Richter T, Bossuyt X, Vermeersch P et al (2012) Determination of IgG and IgA antibodies against native gliadin is not helpful for the diagnosis of coeliac disease in children up to 2 years of age. J Pediatr Gastroenterol Nutr (in press) Richter T, Bossuyt X, Vermeersch P et al (2012) Determination of IgG and IgA antibodies against native gliadin is not helpful for the diagnosis of coeliac disease in children up to 2 years of age. J Pediatr Gastroenterol Nutr (in press)
69.
go back to reference Rodrigues AF, Jenkins HR (2008) Investigation and management of coeliac disease. Arch Dis Child 93:251–254PubMedCrossRef Rodrigues AF, Jenkins HR (2008) Investigation and management of coeliac disease. Arch Dis Child 93:251–254PubMedCrossRef
70.
go back to reference Rubio-Tapia A, Kyle RA, Kaplan EL et al (2009) Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology 137:88–93PubMedCrossRef Rubio-Tapia A, Kyle RA, Kaplan EL et al (2009) Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology 137:88–93PubMedCrossRef
71.
go back to reference Sapone A, Bai J, Ciacci C et al (2012) Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC Med 10:13PubMedCrossRef Sapone A, Bai J, Ciacci C et al (2012) Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC Med 10:13PubMedCrossRef
72.
go back to reference Schuppan D, Hahn EG (2001) IgA anti-tissue transglutaminase: setting the stage for coeliac disease screening. Eur J Gastroenterol Hepatol 13:635–637PubMedCrossRef Schuppan D, Hahn EG (2001) IgA anti-tissue transglutaminase: setting the stage for coeliac disease screening. Eur J Gastroenterol Hepatol 13:635–637PubMedCrossRef
73.
go back to reference Schweizer JJ, Kneepkens CMF et al (2011) The 3rd national survey on childhood celiac disease in the Netherlands: still changing epidemiology and clinical presentation. Swiss Med Wkly 141:14S Schweizer JJ, Kneepkens CMF et al (2011) The 3rd national survey on childhood celiac disease in the Netherlands: still changing epidemiology and clinical presentation. Swiss Med Wkly 141:14S
74.
go back to reference Shiner M (1960) Coeliac disease: histopathological findings in the small intestinal mucosa studies by a peroral biopsy technique. Gut 1:48–54PubMedCrossRef Shiner M (1960) Coeliac disease: histopathological findings in the small intestinal mucosa studies by a peroral biopsy technique. Gut 1:48–54PubMedCrossRef
75.
go back to reference Sollid LM, Thorsby E (1993) HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology 105:910–922PubMed Sollid LM, Thorsby E (1993) HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology 105:910–922PubMed
76.
go back to reference Steens RF, Csizmadia CG, George EK et al (2005) A national prospective study on childhood celiac disease in the Netherlands 1993–2000: an increasing recognition and a changing clinical picture. J Pediatr 147:239–243PubMedCrossRef Steens RF, Csizmadia CG, George EK et al (2005) A national prospective study on childhood celiac disease in the Netherlands 1993–2000: an increasing recognition and a changing clinical picture. J Pediatr 147:239–243PubMedCrossRef
77.
go back to reference Stene LC, Honeyman MC, Hoffenberg EJ et al (2006) Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am J Gastroenterol 101:2333–2340PubMedCrossRef Stene LC, Honeyman MC, Hoffenberg EJ et al (2006) Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am J Gastroenterol 101:2333–2340PubMedCrossRef
78.
go back to reference Tack GJ, Verbeek WH, Schreurs MW, Mulder CJ (2010) The spectrum of celiac disease: epidemiology, clinical aspects and treatment. Nat Rev Gastroenterol Hepatol 7:204–213PubMedCrossRef Tack GJ, Verbeek WH, Schreurs MW, Mulder CJ (2010) The spectrum of celiac disease: epidemiology, clinical aspects and treatment. Nat Rev Gastroenterol Hepatol 7:204–213PubMedCrossRef
79.
go back to reference Thomson M, Kitching P, Jones A et al (1999) Are endoscopic biopsies of small bowel as good as suction biopsies for diagnosis of enteropathy? J Pediatr Gastroenterol Nutr 29:438–441PubMedCrossRef Thomson M, Kitching P, Jones A et al (1999) Are endoscopic biopsies of small bowel as good as suction biopsies for diagnosis of enteropathy? J Pediatr Gastroenterol Nutr 29:438–441PubMedCrossRef
80.
go back to reference Tjon JM, van Bergen J, Koning F (2010) Celiac disease: how complicated can it get? Immunogenetics 62:641–651PubMedCrossRef Tjon JM, van Bergen J, Koning F (2010) Celiac disease: how complicated can it get? Immunogenetics 62:641–651PubMedCrossRef
81.
go back to reference Trynka G, Wijmenga C, van Heel DA (2010) A genetic perspective on coeliac disease. Trends Mol Med 16:537–550PubMedCrossRef Trynka G, Wijmenga C, van Heel DA (2010) A genetic perspective on coeliac disease. Trends Mol Med 16:537–550PubMedCrossRef
82.
go back to reference Trynka G, Hunt KA, Bockett NA et al (2011) Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet 43:1193–1201PubMedCrossRef Trynka G, Hunt KA, Bockett NA et al (2011) Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet 43:1193–1201PubMedCrossRef
83.
go back to reference Turner J, Pellerin G, Mager D (2009) Prevalence of metabolic bone disease in children with celiac disease is independent of symptoms at diagnosis. J Pediatr Gastroenterol Nutr 49:589–593PubMedCrossRef Turner J, Pellerin G, Mager D (2009) Prevalence of metabolic bone disease in children with celiac disease is independent of symptoms at diagnosis. J Pediatr Gastroenterol Nutr 49:589–593PubMedCrossRef
84.
go back to reference Vader W, Stepniak D, Kooy Y et al (2003) The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses. Proc Natl Acad Sci USA 100:12390–12395PubMedCrossRef Vader W, Stepniak D, Kooy Y et al (2003) The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses. Proc Natl Acad Sci USA 100:12390–12395PubMedCrossRef
85.
go back to reference van de Kamer JH, Weijers HA, Dicke WK (1953) Coeliac disease. IV. An investigation into the injurious constituents of wheat in connection with their action on patients with coeliac disease. Acta Paediatr 42:223–231CrossRef van de Kamer JH, Weijers HA, Dicke WK (1953) Coeliac disease. IV. An investigation into the injurious constituents of wheat in connection with their action on patients with coeliac disease. Acta Paediatr 42:223–231CrossRef
86.
go back to reference Verhasselt V (2010) Neonatal tolerance under breastfeeding influence. Curr Opin Immunol 22:623–630PubMedCrossRef Verhasselt V (2010) Neonatal tolerance under breastfeeding influence. Curr Opin Immunol 22:623–630PubMedCrossRef
87.
go back to reference Vermeulen BA, Hogen Esch CE, Yuksel Z et al (2009) Phenotypic variance in childhood coeliac disease and the HLA-DQ/DR dose effect. Scand J Gastroenterol 44:40–45PubMedCrossRef Vermeulen BA, Hogen Esch CE, Yuksel Z et al (2009) Phenotypic variance in childhood coeliac disease and the HLA-DQ/DR dose effect. Scand J Gastroenterol 44:40–45PubMedCrossRef
88.
go back to reference Vivas S, Ruiz de Morales JG, Riestra S et al (2009) Duodenal biopsy may be avoided when high transglutaminase antibody titers are present. World J Gastroenterol 15:4775–4780PubMedCrossRef Vivas S, Ruiz de Morales JG, Riestra S et al (2009) Duodenal biopsy may be avoided when high transglutaminase antibody titers are present. World J Gastroenterol 15:4775–4780PubMedCrossRef
89.
go back to reference Volta U, Tovoli F, Caio G (2011) Clinical and immunological features of celiac disease in patients with type 1 diabetes mellitus. Expert Rev Gastroenterol Hepatol 5:479–487PubMedCrossRef Volta U, Tovoli F, Caio G (2011) Clinical and immunological features of celiac disease in patients with type 1 diabetes mellitus. Expert Rev Gastroenterol Hepatol 5:479–487PubMedCrossRef
90.
go back to reference Volta U, Tovoli F, Cicola R et al (2011) Serological tests in gluten sensitivity (nonceliac gluten intolerance). J Clin Gastroenterol (in press) Volta U, Tovoli F, Cicola R et al (2011) Serological tests in gluten sensitivity (nonceliac gluten intolerance). J Clin Gastroenterol (in press)
91.
go back to reference Wahab PJ, Meijer JW, Dumitra D et al (2002) Coeliac disease: more than villous atrophy. Rom J Gastroenterol 11:121–127PubMed Wahab PJ, Meijer JW, Dumitra D et al (2002) Coeliac disease: more than villous atrophy. Rom J Gastroenterol 11:121–127PubMed
92.
go back to reference Walker-Smith JA, Guandalini S, Schmitz J, Shmerling DH, Visakorpi JK (1990) Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child 65:909–911CrossRef Walker-Smith JA, Guandalini S, Schmitz J, Shmerling DH, Visakorpi JK (1990) Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child 65:909–911CrossRef
94.
go back to reference Wierink CD, van Diermen DE, Aartman IH, Heymans HS (2007) Dental enamel defects in children with coeliac disease. Int J Paediatr Dent 17:163–168PubMedCrossRef Wierink CD, van Diermen DE, Aartman IH, Heymans HS (2007) Dental enamel defects in children with coeliac disease. Int J Paediatr Dent 17:163–168PubMedCrossRef
95.
go back to reference Wolters VM, van de Nadort C, Gerritsen SA et al (2009) Is gluten challenge really necessary for the diagnosis of coeliac disease in children younger than age 2 years? J Pediatr Gastroenterol Nutr 48:566–570PubMedCrossRef Wolters VM, van de Nadort C, Gerritsen SA et al (2009) Is gluten challenge really necessary for the diagnosis of coeliac disease in children younger than age 2 years? J Pediatr Gastroenterol Nutr 48:566–570PubMedCrossRef
96.
go back to reference Wouters J, Weijerman ME, van Furth AM et al (2009) Prospective human leukocyte antigen, endomysium immunoglobulin A antibodies, and transglutaminase antibodies testing for celiac disease in children with Down syndrome. J Pediatr 154:239–242PubMedCrossRef Wouters J, Weijerman ME, van Furth AM et al (2009) Prospective human leukocyte antigen, endomysium immunoglobulin A antibodies, and transglutaminase antibodies testing for celiac disease in children with Down syndrome. J Pediatr 154:239–242PubMedCrossRef
97.
go back to reference Zanini B, Magni A, Caselani F et al (2011) High tissue-transglutaminase antibody level predicts small intestinal villous atrophy in adult patients at high risk of celiac disease. Dig Liver Dis (in press) Zanini B, Magni A, Caselani F et al (2011) High tissue-transglutaminase antibody level predicts small intestinal villous atrophy in adult patients at high risk of celiac disease. Dig Liver Dis (in press)
Metadata
Title
Clinical practice
Coeliac disease
Authors
C. M. Frank Kneepkens
B. Mary E. von Blomberg
Publication date
01-07-2012
Publisher
Springer-Verlag
Published in
European Journal of Pediatrics / Issue 7/2012
Print ISSN: 0340-6199
Electronic ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-012-1714-8

Other articles of this Issue 7/2012

European Journal of Pediatrics 7/2012 Go to the issue